MedTrace Logo

The Drug Induced Renal Injury Consortium

NCT02159209 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 634

Last updated 2016-04-21

No results posted yet for this study

Summary

Some medications are known to cause kidney damage because the person is allergic to the medication while others cause direct damage to the kidney because they are toxic at certain concentrations. Risk factors for developing kidney damage have been identified for some medications but not for all. Patients who are exposed to these important medications and develop problems with their kidneys may have some genetic risk. The purpose of this study is to determine the genetic risk factors for drug induced kidney injury. A better understanding of the role of genetics for the development of kidney injury from medications will allow us to better select medications, improve effectiveness of treatment and minimize harm.

Conditions

Sponsors & Collaborators

  • International Serious Adverse Event Consortium

    collaborator UNKNOWN

  • Ravindra Mehta

    lead OTHER

Principal Investigators

  • Ravindra Mehta, MD · University of California, San Diego

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States
  • Bolivia
  • Canada
  • Chile
  • India
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02159209 on ClinicalTrials.gov